Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Volckmann

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cell Reports|December 8, 2022
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulationMartin F Orth, Didier Surdez, Tobias Faehling, et al.
British Journal of Cancer|February 23, 2022
Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacityJamila Laoukili, Alexander Constantinides, Emma C E Wassenaar, et al.
Communications Medicine|May 17, 2024
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinomaAmber P van der Zalm, Mark P G Dings, Paul Manoukian, et al.
Nature Communications|February 25, 2021
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteomeSabine A Hartlieb, Lina Sieverling, Michal Nadler-Holly, et al.
Nature Genetics|October 9, 2012
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppressionJan J Molenaar, Raquel Domingo-Fernández, Marli E Ebus, et al.
Cancer Cell|February 12, 2015
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumorsJenny Wegert, Naveed Ishaque, Romina Vardapour, et al.
Nature Genetics|June 27, 2017
Neuroblastoma is composed of two super-enhancer-associated differentiation statesTim van Groningen, Jan Koster, Linda J Valentijn, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicineKarin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Cancer Cell|March 1, 2016
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer LandscapesPascal D Johann, Serap Erkek, Marc Zapatka, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cell Reports|December 8, 2022
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulationMartin F Orth, Didier Surdez, Tobias Faehling, et al.
British Journal of Cancer|February 23, 2022
Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacityJamila Laoukili, Alexander Constantinides, Emma C E Wassenaar, et al.
Communications Medicine|May 17, 2024
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinomaAmber P van der Zalm, Mark P G Dings, Paul Manoukian, et al.
Nature Communications|February 25, 2021
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteomeSabine A Hartlieb, Lina Sieverling, Michal Nadler-Holly, et al.
Nature Genetics|October 9, 2012
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppressionJan J Molenaar, Raquel Domingo-Fernández, Marli E Ebus, et al.
Cancer Cell|February 12, 2015
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumorsJenny Wegert, Naveed Ishaque, Romina Vardapour, et al.
Nature Genetics|June 27, 2017
Neuroblastoma is composed of two super-enhancer-associated differentiation statesTim van Groningen, Jan Koster, Linda J Valentijn, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicineKarin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Cancer Cell|May 13, 2015
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsKristian W Pajtler, Hendrik Witt, Martin Sill, et al.
Cancer Cell|March 1, 2016
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer LandscapesPascal D Johann, Serap Erkek, Marc Zapatka, et al.
Pageof 4